Susquehanna International Group, LLP Vaccinex, Inc. Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$0.39 - $0.65 $38,650 - $64,418	99,105 New	99,105 $39,000
Q3 2022 Nov 14, 2022	BUY	$0.48 - $109.22 $28,589 - $6.51 Million	59,561 Added 211.67%	87,700 $43,000
Q2 2022 Aug 15, 2022	SELL	$1.05 - $1.39 $6,701 - $8,870	-6,382 Reduced 18.49%	28,139 $30,000
Q1 2022 May 16, 2022	BUY	$0.92 - $1.94 $11,486 - $24,220	12,485 Added 56.66%	34,521 $46,000
Q4 2021 Feb 14, 2022	SELL	$1.04 - $2.12 $8,498 - $17,324	-8,172 Reduced 27.05%	22,036 $23,000
Q3 2021 Nov 15, 2021	SELL	$2.11 - $2.81 $120,567 - $160,566	-57,141 Reduced 65.42%	30,208 $65,000
Q2 2021 Aug 11, 2021	SELL	$2.01 - $3.0 $44,696 - $66,711	-22,237 Reduced 20.29%	87,349 $245,000
Q1 2021 May 17, 2021	BUY	$2.09 - $5.11 $192,282 - $470,125	92,001 Added 523.18%	109,586 $327,000
Q3 2020 Nov 16, 2020	BUY	$1.75 - $8.19 $30,773 - $144,021	17,585 New	17,585 $31,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $240M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.